By the acquisition of Pronova BioPharma in January 2013, of Equateq, today BASF Pharma (Callanish), in May 2012 and of Cognis in December 2010, BASF became a global market leader for omega-3 fatty acids. The portfolio now covers high-concentrate omega-3 fatty acids for pharmaceuticals and dietary supplements. Besides its broad portfolio, BASF offers global customer reach, solid know-how and scientific expertise in the production of omega-3 fatty acids.
Omega-3 concentrates are produced in our facilities in Sandefjord (Norway) and Callanish (Scotland); headquarters are in Lilleaker (Oslo), Norway.
Company Category
-
Concentrator
- 61-80 pct Concentrated Oil
- 81-90 pct Concentrated Oil
- 91-100 pct Concentrated Oil
- Brand
Raw Material Source
- Algae
- Anchovy
- Fish
- Mackerel
- Sardine
- Tuna
Omega-3 Chemical Form
- Triglyceride
- Ethyl Ester
- rTG
Product Form
- Liquid/oil (Concentrate)
- Soft gels
Finished Product Category
- Clinical Nutrition/Medical Foods
- Dietary Supplement
- Pharmaceutical
